Home > Publications Database > Animal Models of Neointimal Hyperplasia and Restenosis: Species-Specific Differences and Implications for Translational Research. > print

001     163653
005     20230915092425.0
024 7 _ |a 10.1016/j.jacbts.2021.06.006
|2 doi
024 7 _ |a pmid:34869956
|2 pmid
024 7 _ |a pmc:PMC8617545
|2 pmc
024 7 _ |a altmetric:112027360
|2 altmetric
037 _ _ |a DZNE-2022-00399
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ebert, Max L A
|b 0
245 _ _ |a Animal Models of Neointimal Hyperplasia and Restenosis: Species-Specific Differences and Implications for Translational Research.
260 _ _ |a Washington, DC
|c 2021
|b American College of Cardiology
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655113734_6961
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The process of restenosis is based on the interplay of various mechanical and biological processes triggered by angioplasty-induced vascular trauma. Early arterial recoil, negative vascular remodeling, and neointimal formation therefore limit the long-term patency of interventional recanalization procedures. The most serious of these processes is neointimal hyperplasia, which can be traced back to 4 main mechanisms: endothelial damage and activation; monocyte accumulation in the subintimal space; fibroblast migration; and the transformation of vascular smooth muscle cells. A wide variety of animal models exists to investigate the underlying pathophysiology. Although mouse models, with their ease of genetic manipulation, enable cell- and molecular-focused fundamental research, and rats provide the opportunity to use stent and balloon models with high throughput, both rodents lack a lipid metabolism comparable to humans. Rabbits instead build a bridge to close the gap between basic and clinical research due to their human-like lipid metabolism, as well as their size being accessible for clinical angioplasty procedures. Every different combination of animal, dietary, and injury model has various advantages and disadvantages, and the decision for a proper model requires awareness of species-specific biological properties reaching from vessel morphology to distinct cellular and molecular features.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Apo, apolipoprotein
|2 Other
650 _ 7 |a CETP, cholesteryl ester transferase protein
|2 Other
650 _ 7 |a ECM, extracellular matrix
|2 Other
650 _ 7 |a FGF, fibroblast growth factor
|2 Other
650 _ 7 |a HDL, high-density lipoprotein
|2 Other
650 _ 7 |a LDL, low-density lipoprotein
|2 Other
650 _ 7 |a LDLr, LDL receptor
|2 Other
650 _ 7 |a PDGF, platelet-derived growth factor
|2 Other
650 _ 7 |a TGF, transforming growth factor
|2 Other
650 _ 7 |a VLDL, very low-density lipoprotein
|2 Other
650 _ 7 |a VSMC, vascular smooth muscle cell
|2 Other
650 _ 7 |a angioplasty
|2 Other
650 _ 7 |a animal model
|2 Other
650 _ 7 |a neointimal hyperplasia
|2 Other
650 _ 7 |a restenosis
|2 Other
700 1 _ |a Schmidt, Vanessa F
|b 1
700 1 _ |a Pfaff, Lena
|b 2
700 1 _ |a von Thaden, Anne
|0 P:(DE-2719)9000925
|b 3
|u dzne
700 1 _ |a Kimm, Melanie A
|b 4
700 1 _ |a Wildgruber, Moritz
|b 5
773 _ _ |a 10.1016/j.jacbts.2021.06.006
|g Vol. 6, no. 11, p. 900 - 917
|0 PERI:(DE-600)2865010-4
|n 11
|p 900 - 917
|t JACC Basic to translational science
|v 6
|y 2021
|x 2452-302X
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/163653/files/DZNE-2022-00399.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/163653/files/DZNE-2022-00399.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:163653
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000925
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2021
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2020-09-12
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)
|0 LIC:(DE-HGF)CCBYNCNDNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-09-12
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-09-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JACC-BASIC TRANSL SC : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-01-26T13:10:25Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-01-26T13:10:25Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-01-26T13:10:25Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-18
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b JACC-BASIC TRANSL SC : 2021
|d 2022-11-18
920 1 _ |0 I:(DE-2719)1140012
|k Animal Facility (Mouse) München
|l Animal Facility (Mouse)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1140012
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21